Breaking News

Lonza’s Ibex Solutions to Support Genmab’s Clinical Portfolio

New agreement will cover development and clinical manufacturing of drug substance and drug product for certain programs in Genmab’s pipeline

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza has extended its partnership with Genmab to cover preclinical and clinical development and manufacturing for a significant portion of Genmab’s pipeline leveraging its Ibex Solutions in Visp.    Lonza’s Ibex Design offering aims to take Genmab’s candidates from gene to IND in 12 months and then move to reserved manufacturing capacity in Ibex Develop for clinical manufacturing and BLA submission. The agreement aims to provide Genmab with security of supply and to enable Genmab to move rapi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters